Transforming Scientists into Managers

A year in management overwhelmed microbiologist Dennis J. Henner, and he retreated to the bench. The time was the mid-1980s. The company: Genentech Inc. in South San Francisco, a biotechnology pioneer that had vowed to make recombinant DNA technology a commercial success. The young bench scientist scaled the career ladder by steering a team of company scientists. But after only a year as a department manager, he decided he had his fill of leadership. "One, I wasn't ready. I was more focused on

Written byPeg Brickley
| 5 min read

Register for free to listen to this article
Listen with Speechify
0:00
5:00
Share

But after only a year as a department manager, he decided he had his fill of leadership. "One, I wasn't ready. I was more focused on the science," says Henner, who would eventually re-enter management and, in the1990s, become the company's senior vice president of research. "And two, I had not really had much exposure to management, especially managing peers, other scientists. It was not a simple transition."

Courtesy of Dennis Henner

Dennis Henner

The transition took Henner about five years. In that time, he says, he learned to look beyond his own research aims and developed an understanding of the intersection between the scientists' careers and the company goals. Such lessons have proven so valuable to young scientists who take on management roles they have become a staple of Genentech's internal training procedures; these lessons in leadership have also become critical to work in academic laboratories.

"Universities are very ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies